Author Archives: Marianne Duparc

Osivax Awarded Grant from a Leading Non-Governmental Organization for OVX836, its Broad-Spectrum Influenza Vaccine A Bill & Melinda Gates Foundation grant will be used to expand research and development of OVX836 in a wide range of seasonal and highly pathogenic influenza strains  Osivax continues evaluating OVX836 across several phase 2 clinical trials in healthy volunteers …

Continue reading “Osivax Awarded Grant from a Leading Non-Governmental Organization for OVX836, its Broad-Spectrum Influenza Vaccine”

Osivax Appoints Dr. Chris Martin, Renowned Biotech Entrepreneur, to its Board of Directors Company honors Dr. Michael Watson for his significant impact as member of Board of Directors Lyon, France – February 23, 2023 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, announced today the appointment …

Continue reading “Osivax Appoints Dr. Chris Martin, Renowned Biotech Entrepreneur, to its Board of Directors”